| Sharon N Garber, NP | |
|
1076 N Main St, Providence, RI 02904-5760 | |
| (401) 861-7711 | |
| (401) 421-5710 |
| Full Name | Sharon N Garber |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Primary Care |
| Location | 1076 N Main St, Providence, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396736229 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | NPP29225 (Rhode Island) | Primary |
| 363LP2300X | Nurse Practitioner - Primary Care | NPP29225 (Rhode Island) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sharon N Garber, NP 1076 N Main St, Providence, RI 02904-5760 Ph: (401) 861-7711 | Sharon N Garber, NP 1076 N Main St, Providence, RI 02904-5760 Ph: (401) 861-7711 |
News Archive
ARIAD Pharmaceuticals, Inc. today announced the completion of patient enrollment in its pivotal, Phase 3 clinical trial of oral ridaforolimus, its investigational mTOR inhibitor, in patients with metastatic soft-tissue and bone sarcomas.
Falls and fractures among senior citizens have increased since rofecoxib was removed from the market in 2004, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.
Black patients aged less than 35 years and without private insurance are less likely to receive assessment for kidney transplant on starting dialysis than other individuals, researchers report.
Scientists at the Stanford University School of Medicine have identified a molecular pathway responsible for the death of key nerve cells whose loss causes Parkinson's disease. This discovery not only may explain how a genetic mutation linked to Parkinson's causes the cells' death, but could also open the door to new therapeutic approaches for the malady.
› Verified 6 days ago